Equities

Astec Lifesciences Ltd

Astec Lifesciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)1,233.80
  • Today's Change8.80 / 0.72%
  • Shares traded25.21k
  • 1 Year change-8.61%
  • Beta0.4857
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy1
Outperform0
Hold0
Sell0
Strong Sell0

Share price forecast in INR

The one analyst offering a 12 month price target expects Astec LifeSciences Limited share price to rise to 1,500.00 in the next year from the last price of 1,225.00.
High22.4%1,500.00
Med22.4%1,500.00
Low22.4%1,500.00

Dividends

Historical dividend information is not available for Astec Lifesciences Ltd.
Div growth (TTM)--
More ▼

Earnings history & estimates in INR

On May 02, 2022, earnings of 21.96 per share.
Average growth rate+48.91%
Astec LifeSciences Limited reported annual 2024 losses of -23.93 per share on May 02, 2024.
Average growth rate+16.11%
More ▼

Revenue history & estimates in INR

Astec LifeSciences Limited had revenues for the full year 2024 of 4.58bn. This was 27.06% below the prior year's results.
Average growth rate+4.12%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.